HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jia Ni Selected Research

periplocoside A

8/2009Periplocoside A prevents experimental autoimmune encephalomyelitis by suppressing IL-17 production and inhibits differentiation of Th17 cells.
9/2008Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jia Ni Research Topics

Disease

6Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2009 - 06/2006
5Periodontitis
01/2018 - 11/2013
2Atherosclerosis
06/2021 - 08/2009
2Pain (Aches)
01/2021 - 01/2021
2Type 2 Diabetes Mellitus (MODY)
01/2020 - 02/2015
2Inflammation (Inflammations)
01/2018 - 09/2006
2Obesity
01/2018 - 11/2013
2Insulin Resistance
01/2018 - 01/2017
2Multiple Sclerosis
05/2007 - 09/2006
1Fibrosis (Cirrhosis)
12/2021
1Chronic Pain
01/2021
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2021
1Hyperalgesia
01/2021
1Neuralgia (Stump Neuralgia)
01/2021
1Pruritus (Itching)
01/2021
1Pneumonia (Pneumonitis)
01/2019
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Infections
01/2019
1Anemia
01/2019
1Dyslipidemias (Dyslipidemia)
01/2017
1Persistent Infection
01/2015
1Acatalasia (Acatalasemia)
06/2014
1Hemorrhage
02/2014
1Necrosis
09/2008
1Hepatitis
09/2008
1Immune System Diseases (Immune Disorders)
06/2007
1Hypersensitivity (Allergy)
02/2006

Drug/Important Bio-Agent (IBA)

3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 02/2014
3InterleukinsIBA
02/2015 - 09/2006
2oxidized low density lipoproteinIBA
06/2021 - 08/2009
2Therapeutic UsesIBA
08/2009 - 09/2006
2periplocoside AIBA
08/2009 - 09/2008
1TransglutaminasesIBA
12/2021
1Long Noncoding RNAIBA
06/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Pregabalin (Lyrica)FDA Link
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1AntipruriticsIBA
01/2021
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
01/2021
1Calcium Channels (Calcium Channel)IBA
01/2021
1Streptozocin (Streptozotocin)FDA Link
01/2021
1LigandsIBA
01/2021
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2020
1Oxygen (Dioxygen)IBA
01/2019
1Hemoglobins (Hemoglobin)IBA
01/2019
1EnzymesIBA
01/2019
1AlbuminsIBA
01/2019
1Serum AlbuminIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Blood Glucose (Blood Sugar)IBA
01/2017
1Insulin (Novolin)FDA Link
01/2017
1LipidsIBA
01/2017
1SilkFDA Link
01/2017
1Neutralizing AntibodiesIBA
01/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2014
1CatalaseIBA
06/2014
1C-Reactive ProteinIBA
02/2014
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
02/2014
1Sodium Glutamate (Accent)IBA
11/2013
1Chemokine ReceptorsIBA
12/2009
1Peptides (Polypeptides)IBA
12/2009
1TAK 779IBA
12/2009
1myelin oligodendrocyte glycoprotein (35-55)IBA
08/2009
1Biological ProductsIBA
08/2009
1Interleukin-17 (Interleukin 17)IBA
08/2009
1Concanavalin AIBA
09/2008
1InterferonsIBA
09/2008
1CytokinesIBA
09/2008
1Alanine Transaminase (SGPT)IBA
09/2008
1pregnane glycosideIBA
09/2008
1SM905IBA
06/2007
1rofecoxib (Vioxx)FDA Link
05/2007
1Interleukin-10 (Interleukin 10)IBA
05/2007
1lumiracoxib (prexige)IBA
05/2007
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
05/2007
1HomocysteineIBA
11/2006
1HydrolasesIBA
11/2006
1periplocoside EIBA
09/2006
1Interferon-gamma (Interferon, gamma)IBA
09/2006
1triptolideIBA
06/2006
1OvalbuminIBA
02/2006
1AntigensIBA
02/2006

Therapy/Procedure

3Therapeutics
12/2021 - 01/2017
3Ligation
01/2018 - 11/2013
1Artificial Respiration (Mechanical Ventilation)
01/2019
1Root Planing
01/2018